FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069854575> ?p ?o ?g. }

• W2069854575 abstract "<h3>Background</h3>Current evidence suggests that there is an association between bisphosphonate therapy and atypical femoral fractures, but the extent of this risk remains unclear.<h3>Methods</h3>Between 1999 and 2010, a total of 477 patients 50 years and older were hospitalized with a subtrochanteric or femoral shaft fracture at a single university medical center. Admission radiographs and medical and treatment records were examined, and patients were classified as having atypical or classic femoral fractures. A random sample of 200 healthy individuals without femoral fracture were also identified. Multivariate logistic regression was used to assess the association of bisphosphonate use and atypical femoral fracture, and the incidence rates of each type of fracture over time were calculated.<h3>Results</h3>Thirty-nine patients with atypical fractures and 438 patients with classic fractures were identified. Of the patients with atypical fractures, 32 (82.1%) had been treated with bisphosphonates compared with 28 (6.4%) in the classic fractures group (odds ratios [OR], 66.9; 95% CI, 27.1-165.1) and 11.5% in the group without fracture (OR, 35.2; 95% CI, 13.9-88.8). Bisphosphonate use was associated with a 47% reduction in risk of classic fracture (OR, 0.5; 95% CI, 0.3-0.9). Considering the duration of use, the ORs (95% CIs) for atypical fractures were 35.1 (10.0-123.6) for less than 2 years, 46.9 (14.2-154.4) for 2 to 5 years, 117.1 (34.2-401.7) for 5 to 9 years, and 175.7 (30.0-1027.6) for more than 9 years compared with no use. A contralateral fracture occurred in 28.2% of atypical cases and in 0.9% of classic cases (OR, 42.6; 95% CI, 12.8-142.4). The incidence rate of atypical fractures was low (32 cases per million person-years) and increased by 10.7% per year on average.<h3>Conclusions</h3>Atypical femoral fractures were associated with bisphosphonate use; longer duration of treatment resulted in augmented risk. The incidence of atypical fractures increased over a 12-year period, but the absolute number of such fractures is very small." @default.
• W2069854575 created "2016-06-24" @default.
• W2069854575 creator A5010312221 @default.
• W2069854575 creator A5021212735 @default.
• W2069854575 creator A5057999899 @default.
• W2069854575 creator A5067918118 @default.
• W2069854575 creator A5082866696 @default.
• W2069854575 date "2012-06-25" @default.
• W2069854575 modified "2023-10-10" @default.
• W2069854575 title "Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use" @default.
• W2069854575 cites W1518317880 @default.
• W2069854575 cites W1859314208 @default.
• W2069854575 cites W1964983463 @default.
• W2069854575 cites W1977778272 @default.
• W2069854575 cites W1987523709 @default.
• W2069854575 cites W2003092614 @default.
• W2069854575 cites W2003635599 @default.
• W2069854575 cites W2006021879 @default.
• W2069854575 cites W2008756438 @default.
• W2069854575 cites W2010029465 @default.
• W2069854575 cites W2019104204 @default.
• W2069854575 cites W2022094899 @default.
• W2069854575 cites W2023649596 @default.
• W2069854575 cites W2037927763 @default.
• W2069854575 cites W2044147129 @default.
• W2069854575 cites W2051516578 @default.
• W2069854575 cites W2070262254 @default.
• W2069854575 cites W2073844603 @default.
• W2069854575 cites W2076490579 @default.
• W2069854575 cites W2082239474 @default.
• W2069854575 cites W2094638050 @default.
• W2069854575 cites W2108734579 @default.
• W2069854575 cites W2124527463 @default.
• W2069854575 cites W2135327653 @default.
• W2069854575 cites W2153009489 @default.
• W2069854575 cites W2158254263 @default.
• W2069854575 cites W2161837912 @default.
• W2069854575 cites W2169251377 @default.
• W2069854575 cites W2321227665 @default.
• W2069854575 cites W2338130968 @default.
• W2069854575 cites W2339217045 @default.
• W2069854575 cites W2412436279 @default.
• W2069854575 cites W2624963411 @default.
• W2069854575 cites W2998979285 @default.
• W2069854575 cites W2018385240 @default.
• W2069854575 doi "https://doi.org/10.1001/archinternmed.2012.1796" @default.
• W2069854575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22732749" @default.
• W2069854575 hasPublicationYear "2012" @default.
• W2069854575 type Work @default.
• W2069854575 sameAs 2069854575 @default.
• W2069854575 citedByCount "184" @default.
• W2069854575 countsByYear W20698545752012 @default.
• W2069854575 countsByYear W20698545752013 @default.
• W2069854575 countsByYear W20698545752014 @default.
• W2069854575 countsByYear W20698545752015 @default.
• W2069854575 countsByYear W20698545752016 @default.
• W2069854575 countsByYear W20698545752017 @default.
• W2069854575 countsByYear W20698545752018 @default.
• W2069854575 countsByYear W20698545752019 @default.
• W2069854575 countsByYear W20698545752020 @default.
• W2069854575 countsByYear W20698545752021 @default.
• W2069854575 countsByYear W20698545752022 @default.
• W2069854575 countsByYear W20698545752023 @default.
• W2069854575 crossrefType "journal-article" @default.
• W2069854575 hasAuthorship W2069854575A5010312221 @default.
• W2069854575 hasAuthorship W2069854575A5021212735 @default.
• W2069854575 hasAuthorship W2069854575A5057999899 @default.
• W2069854575 hasAuthorship W2069854575A5067918118 @default.
• W2069854575 hasAuthorship W2069854575A5082866696 @default.
• W2069854575 hasConcept C120665830 @default.
• W2069854575 hasConcept C121332964 @default.
• W2069854575 hasConcept C126322002 @default.
• W2069854575 hasConcept C141071460 @default.
• W2069854575 hasConcept C151956035 @default.
• W2069854575 hasConcept C156957248 @default.
• W2069854575 hasConcept C195910791 @default.
• W2069854575 hasConcept C2776541429 @default.
• W2069854575 hasConcept C2777251235 @default.
• W2069854575 hasConcept C2780012534 @default.
• W2069854575 hasConcept C2780554211 @default.
• W2069854575 hasConcept C36454342 @default.
• W2069854575 hasConcept C61511704 @default.
• W2069854575 hasConcept C71924100 @default.
• W2069854575 hasConceptScore W2069854575C120665830 @default.
• W2069854575 hasConceptScore W2069854575C121332964 @default.
• W2069854575 hasConceptScore W2069854575C126322002 @default.
• W2069854575 hasConceptScore W2069854575C141071460 @default.
• W2069854575 hasConceptScore W2069854575C151956035 @default.
• W2069854575 hasConceptScore W2069854575C156957248 @default.
• W2069854575 hasConceptScore W2069854575C195910791 @default.
• W2069854575 hasConceptScore W2069854575C2776541429 @default.
• W2069854575 hasConceptScore W2069854575C2777251235 @default.
• W2069854575 hasConceptScore W2069854575C2780012534 @default.
• W2069854575 hasConceptScore W2069854575C2780554211 @default.
• W2069854575 hasConceptScore W2069854575C36454342 @default.
• W2069854575 hasConceptScore W2069854575C61511704 @default.
• W2069854575 hasConceptScore W2069854575C71924100 @default.
• W2069854575 hasIssue "12" @default.
• W2069854575 hasLocation W20698545751 @default.
• W2069854575 hasLocation W20698545752 @default.

• next